Global Biosimulation Market Size study, by Component (Software, Service), by Application (Drug Development, Drug Discovery, Others), by Industry (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Regulatory Authorities, Academic Research Institutes), and Regional Forecasts 2018-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Biosimulation Market valued approximately USD 1.9 billion in 2017 is anticipated to grow with a healthy growth rate of more than 15.5% over the forecast period 2017-2025. Increasing need for the treatment with higher impact and low susceptibility to drug resistance and its requirement in Proteomic and Geomic technologies for development of advance therapeutics are the major factors driving the growth in the Global Biosimulation Market. However, the absence of proper standardization in the biosimulation methodology and lack of knowledge is likely to act as a major cause of concern. Biosimulation market is a tool for mathematical simulation of biological processes and systems. It provides model based calculation of biological system and processes and helps in drug discovery and development with the prediction of its failure and success. It helps in reduction of efforts and cost of drug development.

Global Biosimulation MarketThe regional analysis of Global Biosimulation Market is considered for the key regions such as North America, Europe, Asia and LAMEA and Rest of the World. North America is the leading/significant region across the world in terms of market share and possesses half of the total market share of the total market. Whereas Europe stands next for Global biosimulation market where Growth is Driven by government initiative.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Component:

  • Software
  • Service
    • In-house Services
    • Contract Services

By Application:

  • Drug Development
  • Drug Discovery
  • Others

By Industry:

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Regulatory Authorities
  • Academic Research Institutes

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016

Base year – 2017

Forecast period – 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include Simulation Plus, Inc., Dassault Systems SA, Schrodinger, Inc., Advanced Chemistry Development Inc, Physiomics PLC, Entelos, Inc., Rhenovia Pharma Ltd., Genedata AG, Leadscope, Inc., InhibOx Ltd. and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Biosimulation Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Chapter 1.           Global Biosimulation Market Definition and Scope

1.1.         Research Objective

1.2.         Market Definition

1.3.         Scope of The Study

1.4.         Years Considered for The Study

1.5.         Currency Conversion Rates

1.6.         Report Limitation

Chapter 2.           Research Methodology

2.1.         Research Process

2.1.1.     Data Mining

2.1.2.     Analysis

2.1.3.     Market Estimation

2.1.4.     Validation

2.1.5.     Publishing

2.2.         Research Assumption

Chapter 3.           Executive Summary

3.1.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

3.2.         Key Trends

Chapter 4.           Global Biosimulation Market Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.2.1.     Porter’s 5 Force Model

4.2.2.     PEST Analysis

4.2.3.     Value Chain Analysis

4.3.         Analyst Recommendation & Conclusion

Chapter 5.           Global Biosimulation Market, By Product

5.1.         Market Snapshot

5.2.         Market Performance – Potential Model

5.3.         Global Biosimulation Market, Sub Segment Analysis

5.3.1.     Software

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.     Service

5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.3. Sub segment breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.3.1.              In-house Services

5.3.2.3.2.              Contract Services            

Chapter 6.           Global Biosimulation Market, By Application

6.1.         Market Snapshot

6.2.         Market Performance – Potential Model

6.3.         Global Biosimulation Market, Sub Segment Analysis

6.3.1.     Drug Development

6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.     Drug Discovery

6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.     Others

6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7.           Global Biosimulation Market, By Industry

7.1.         Market Snapshot

7.2.         Market Performance – Potential Model

7.3.         Global Biosimulation Market, Sub Segment Analysis

7.3.1.     Pharmaceutical & Biotechnology Companies

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.     Contract Research Organizations (CROs)

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.     Regulatory Authorities

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.     Academic Research Institutes

7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)       

Chapter 8.           Global Biosimulation Market, by Regional Analysis

8.1.         Biosimulation Market, Regional Market Snapshot (2015-2025)

8.2.         North America Biosimulation Market Snapshot

8.2.1.     U.S.

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.     Canada

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.         Europe Biosimulation Market Snapshot

8.3.1.     U.K.

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.     Germany

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.     France

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.     Rest of Europe

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.         Asia Biosimulation Market Snapshot

8.4.1.     China

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.     India

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.     Japan

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.     Rest of Asia Pacific

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.         Latin America Biosimulation Market Snapshot

8.5.1.     Brazil

8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.     Mexico

8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.         Rest of The World

8.6.1.     South America

8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2. Deployment breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3. Organization Size breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4. Industry breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.     Middle East and Africa

8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.2. Deployment breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.3. Organization Size breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.4. Industry breakdown estimates & forecasts, 2015-2025 (USD Billion)                                       

Chapter 9.           Competitive Intelligence

9.1.         Company Market Share (Subject to Data Availability)

9.2.         Top Market Strategies

9.3.         Company Profiles

9.3.1.     Certara USA, Inc.

9.3.1.1. Key Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2.     Simulation Plus, Inc.

9.3.3.     Dassault Systems SA

9.3.4.     Schrodinger, Inc

9.3.5.     Advanced Chemistry Development, Inc

9.3.6.     Physiomics PLC.

9.3.7.     Entelos, Inc.

9.3.8.     Rhenovia Pharma Ltd.

9.3.9.     Genedata AG

9.3.10.   Leadscope, Inc

9.3.11.   InhibOx Ltd

The Research Methodology for Global Biosimulation Study focuses deeply on the entire value chain of the market. However, all of the estimates are purely based on the consumption/implementation side of the value chain wherein the market sizes have been calculated by analyzing the average demand/procedures/usage/deployment of Biosimulation across various applications such as drug development and drug discovery.

The whole industry has been divided into various segments i.e. Product, Component, Application, Vertical, End-Use and Regions and each of which is studied as an individual study by our research analysts and consultants. Each of the subsegments has been analyzed and estimated at country level to form a regional scope. After finalizing the regional and segmental revenues the total revenue for Global Biosimulation Market is calculated as a sum of all the different segments.

Some of the key data points considered to calculate the revenue for Global Biosimulation Market includes:

  • Revenues from key companies
  • Company market share analysis
  • Consumer spending analysis
  • Regional export and import analysis
  • Regulatory Trends
  • Sales revenue generated by various products/applications in different countries/geographies

The research process begins with extensive data mining, using paid & free authentic information sources such as white papers, industry journals, trade magazines, hoovers, factiva, statista, news websites, technical publications, independent studies etc. a team of dedicated research analysts and associates work on all of the gathered data to extract relevant information. Key factors such as ongoing & upcoming industry trends, external & internal driving factors, restraining factors, growth opportunities and value chain analysis has been verified in order form qualitative part of the report and to back the market estimation team for quantitative analysis.

We utilize a combination top-down and bottom-up methodology for market estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the market estimates and forecasts through primary interviews and feedbacks. An extensive primary and secondary research have been conducted with the key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify industry trends and market estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

All the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from each other are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts.  


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…